Efficacy and safety of levodopa-carbidopa intestinal gel from a study in Japanese, Taiwanese, and Korean advanced Parkinson's disease patients (Q33917449)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Efficacy and safety of levodopa-carbidopa intestinal gel from a study in Japanese, Taiwanese, and Korean advanced Parkinson's disease patients	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Efficacy and safety of levodopa-carbidopa intestinal gel from a study in Japanese, Taiwanese, and Korean advanced Parkinson's disease patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

Masahito Mihara

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Miho Murata

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Kazuko Hasegawa

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Beomseok Jeon

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Chon-Haw Tsai

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Noriko Nishikawa

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Tomoko Oeda

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Masayuki Yokoyama

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Weining Z Robieson

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Davis Ryman

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Susan Eaton

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Krai Chatamra

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Janet Benesh

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

3 November 2016

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

NPJ Parkinson's disease

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

16020

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

copyright license

Creative Commons Attribution 4.0 International

3 November 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516619

28 July 2018

Jejunal Infusion of levodopa-carbidopa intestinal gel versus oral administration of levodopa-carbidopa tablets in japanese subjects with advanced Parkinson's disease: pharmacokinetics and pilot efficacy and safety

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516619

28 July 2018

Prevalence of wearing-off and dyskinesia among the patients with Parkinson's disease on levodopa therapy: a multi-center registry survey in mainland China

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516619

28 July 2018

Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516619

28 July 2018

Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516619

28 July 2018

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516619

28 July 2018

Complications after percutaneous endoscopic gastrostomy in a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516619

28 July 2018

Pharmacokinetics of levodopa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516619

28 July 2018

Pathogenesis of dyskinesias in Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516619

28 July 2018

Ethnic differences in drug disposition and responsiveness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516619

28 July 2018

Levodopa motor complications in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2016.20

21 January 2018

When the going gets tough: how to select patients with Parkinson's disease for advanced therapies

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2016.20

21 January 2018

Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2016.20

21 January 2018

Multidisciplinary practical guidelines for gastrointestinal access for enteral nutrition and decompression from the Society of Interventional Radiology and American Gastroenterological Association (AGA) Institute, with endorsement by Canadian Interv

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2016.20

21 January 2018

The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2016.20

21 January 2018

Long-term safety and maintenance of efficacy of levodopa-carbidopa intestinal gel: an open-label extension of the double-blind pivotal study in advanced Parkinson's disease patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5516619

29 October 2018

Clinical features and varieties of non-motor fluctuations in Parkinson's disease: A Japanese multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2016.20

21 January 2018

Temporal relationships between plasma and cerebrospinal fluid pharmacokinetics of levodopa and clinical effect in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2016.20

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of levodopa

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2016.20

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2016.20

7 January 2021

based on heuristic

inferred from DOI database lookup

Motor and non-motor symptoms of 1453 patients with Parkinson's disease: prevalence and risks

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2016.20

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2016.20

7 January 2021

based on heuristic

inferred from DOI database lookup

Difference in erythrocyte catechol-O-methyltransferase activity between Orientals and Caucasians: difference in levodopa tolerance

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2016.20

7 January 2021

based on heuristic

inferred from DOI database lookup

A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia

1 reference

https://api.crossref.org/works/10.1038%2FNPJPARKD.2016.20

7 January 2021

based on heuristic

inferred from DOI database lookup

[Analysis of application form for Parkinson's disease provided by the specific diseases treatment research program of Ministry of Health, Labour and Welfare of Japan]

1 reference

https://pubmed.ncbi.nlm.nih.gov/28725701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/NPJPARKD.2016.20

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725701%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33917449&oldid=2195991572"